Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether \[18F\]FHBG is suitable for use as an imaging probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In this phase ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sanjiv Sam Gambhir
NCT02800486 · Glioblastoma, Anaplastic Astrocytoma, and more
NCT05386108 · Breast Neoplasms, Brain Neoplasms, and more
NCT05961592 · Arthritis, Rheumatoid
NCT07017686 · Arthritis, Rheumatoid
NCT02691923 · Brain Cancer
University of California Los Angeles
Los Angeles, California
Stanford University School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions